Vancouver, British Columbia – TheNewswire - May 13, 2022. Lexston Life Sciences Corp. (the “Company” or “Lexston”) (CSE:LEXT) (OTC:LEXTF) announces that its board of directors approved the consolidation of the common shares of the Company on the ratio of five (5) pre-consolidated shares for one (1) post-consolidated share.  The effective date and timing of the share consolidation will be determined and announced at a later date.

On Behalf of the Board of Directors

LEXSTON LIFE SCIENCES CORP.

Jagdip Bal Chief Executive Officer

Telephone: (604) 928-8913

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.